A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose–lipid control in type 2 diabetes

✍ Scribed by A. P. S. Kong; A. Yamasaki; R. Ozaki; H. Saito; T. Asami; S. Ohwada; G. T. C. Ko; C. K. Wong; G. T. C. Leung; K. F. Lee; C. Y. Yeung; J. C. N. Chan

• Book ID: 109046150
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 589 KB
• Volume: 13
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/j.1463-1326.2011.01411.x